Grünenthal GmbH
Budget
€50 — €0
EP Access
0
accredited persons
Staff
1
0.1 FTE
EU Grants
None
Mission & Goals
Grünenthal is a global leader in pain management and related diseases. As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all our activities and efforts on moving towards our vision of a world free of pain. As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to people living with pain worldwide. Strong ongoing partnerships with leading healthcare and development organisations bring our new products to life. We’re a fully integrated pharmaceutical company that offers support along the entire value chain – from drug development through to commercialisation. Grünenthal is headquartered in Aachen, Germany, and has affiliates in 15 countries across Europe.
EU Legislative Interests
Grünenthal's interests in Brussels deal with issues related to health- and pain care, pharmaceuticals, innovation, research and intellectual property. Grünenthal is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and therefore involved in following main legislative proposals and policies: Pharmaceutical strategy, Review of incentives and rewards, Europe’s Beating Cancer plan, Regulation on Health Technology Assessments, Regulation to create an EU Health Emergency Response Authority (HERA) , Regulation on a European Health Data Space, Cross-border healthcare, Mental Health policy
Communication Activities
Grünenthal is dedicated to creating a better future for pain patients, so getting involved with diverse initiatives that support this goal is vital. For example, Grünenthal supports the multi-stakeholder platform Societal Impact of Pain (SIP) which initiates projects, arranges events with policy maker and releases position paper on following topics: - EU Health Policy topics like EU Cancer Plan / Mental Health - Employment and social integration of patients such as European Pillar of social Rights - Pain and digital medicine / eHealth / telehealth policies You find an overview of our initiatives here: https://www.grunenthal.com/about-us/initiatives
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Grünenthal is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA): http://www.efpia.eu as well as of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA): https://www.ifpma.org/ and has signed their respective codes. Grünenthal is a sponsor the Societal Impact of Pain (SIP) platform. More info can be found here: https://europeanpainfederation.eu/sip/
Organisation Members
Societal Impact of Pain (SIP) https://europeanpainfederation.eu/sip/
Commissioner Meetings
No recorded meetings with EU commissioners.